GSE207376 GSE207377 nutlin-3 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE207376_GSE207377_nutlin-3_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE207376_GSE207377_nutlin-3_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE207376_GSE207377_nutlin-3_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE207376_GSE207377_nutlin-3_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

mir-100-let-7a-2-mir-125b-1 cluster host gene

Gene

NF-kappaB interacting lncRNA

Gene

PRR34 antisense RNA 1

Gene

WT1 antisense RNA

Gene

DPY19L2 pseudogene 1

Gene

H1.9 linker histone, pseudogene

Gene

uncharacterized LOC107986163

Gene

uncharacterized LOC105377139

Gene

mitochondrial ribosomal protein L45 pseudogene 2

Gene

PROX1 antisense RNA 1

  • Gene

    mir-100-let-7a-2-mir-125b-1 cluster host gene


  • Gene

    NF-kappaB interacting lncRNA


  • Gene

    PRR34 antisense RNA 1


  • Gene

    WT1 antisense RNA


  • Gene

    DPY19L2 pseudogene 1


  • Gene

    H1.9 linker histone, pseudogene


  • Gene

    uncharacterized LOC107986163


  • Gene

    uncharacterized LOC105377139


  • Gene

    mitochondrial ribosomal protein L45 pseudogene 2


  • Gene

    PROX1 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.